{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:47:05Z","timestamp":1770976025507,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[1996,5,1]],"date-time":"1996-05-01T00:00:00Z","timestamp":830908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Chemical Neuropathology"],"published-print":{"date-parts":[[1996,5]]},"DOI":"10.1007\/bf02815208","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T11:51:24Z","timestamp":1211975484000},"page":"83-88","source":"Crossref","is-referenced-by-count":39,"title":["Inflammation and Alzheimer disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Paul S.","family":"Aisen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1996,5,1]]},"reference":[{"key":"BF02815208_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0092-8674(88)90462-X","volume":"52","author":"C. R. Abraham","year":"1988","unstructured":"Abraham C. R., Selkoe D. J., and Potter H. (1988) Immunohistochemical identification of the serine protease inhibitor alpha-1 antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.Cell\n52, 487\u2013501.","journal-title":"Cell"},{"key":"BF02815208_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0197-4580(90)90045-2","volume":"11","author":"C. R. Abraham","year":"1990","unstructured":"Abraham C. R., Shirahama T., and Potter H. (1990) The protease inhibitor \u03b11-antichymotrypsin is associated solely with amyloid deposits containing the \u03b2-protein and is localized in specific cells of both normal and diseased brain.Neurobiol. Aging\n11, 123\u2013129.","journal-title":"Neurobiol. Aging"},{"key":"BF02815208_CR3","unstructured":"Aisen P. S., Marin D., Altstiel L., Goodwin C., Baruch B., Jacobson R., Ryan T., and Davis K. L. A pilot study of prednisone in Alzheimer's disease.Dementia, in press."},{"key":"BF02815208_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1176\/ajp.151.8.1105","volume":"151","author":"P. S. Aisen","year":"1994","unstructured":"Aisen P. S. and Davis K. L. (1994) Inflammatory mechanisms in Alzheimer's disease: Implications for therapy.Am. J. Psychiatry\n151, 1105\u20131113.","journal-title":"Am. J. Psychiatry"},{"key":"BF02815208_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0278-5846(91)90023-T","volume":"15","author":"L. Altstiel","year":"1991","unstructured":"Altstiel L. and Sperber K. (1991) Cytokines in Alzheimer's disease.Prog. Neuro. Psychopharmacol. Biol. Psychiat.\n15, 481\u2013495.","journal-title":"Prog. Neuro. Psychopharmacol. Biol. Psychiat."},{"key":"BF02815208_CR6","first-page":"17","volume":"6","author":"L. D. Altstiel","year":"1995","unstructured":"Altstiel L. D., Lawlor B., Mohs R., Schmeidler J., Dalton A., Mehta P., and Davis K. (1995) Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patients.Dementia\n6, 17\u201320.","journal-title":"Dementia"},{"key":"BF02815208_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1212\/WNL.44.2.227","volume":"44","author":"J. C. Breitner","year":"1994","unstructured":"Breitner J. C., Gau B. A., Welsh K. A., Plassman B. L., McDonald W. M., Helms M. J., and Anthony J. C. (1994) Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.Neurology\n44, 227\u2013232.","journal-title":"Neurology"},{"key":"BF02815208_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.410320211","volume":"32","author":"K. Brugge","year":"1992","unstructured":"Brugge K., Katzman R., Hill L. R., Hansen L. A., and Saitoh T. (1992) Serological \u03b11-antichymotrypsin in Down's syndrome and Alzheimer's disease.Ann. Neurol.\n32, 193\u2013197.","journal-title":"Ann. Neurol."},{"key":"BF02815208_CR9","doi-asserted-by":"publisher","first-page":"10,061","DOI":"10.1073\/pnas.90.21.10061","volume":"90","author":"I. L. Campbell","year":"1993","unstructured":"Campbell I. L., Abraham C. R., Masliah E., Kemper P., Inglis J. D., Oldstone M. B. A., and Mucke L. (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.Proc. Natl. Acad. Sci. USA\n90 10,061\u201310,065.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02815208_CR10","first-page":"431","volume-title":"Drugs for Rheumatic Disease","author":"Y.-H. Chang","year":"1987","unstructured":"Chang Y.-H., Silverman S. L., and Paulus H. E. (1987) Colchicine, inDrugs for Rheumatic Disease (Paulus H. E., Furst D. E., and Droomgoole, eds.), pp. 431, Churchhill Livingstone, New York."},{"key":"BF02815208_CR11","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","volume":"23","author":"C. DeDuve","year":"1974","unstructured":"DeDuve C., DeBarsy T., Poole B., Trouet A., Tulkens P., and van Hoof F. (1974) Lysosomotropic agents.Biochem. Pharmac.\n23, 2495\u20132531.","journal-title":"Biochem. Pharmac."},{"key":"BF02815208_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00685397","volume":"57","author":"P. Eikelenboom","year":"1982","unstructured":"Eikelenboom P. and Stam F. C. (1982) Immunoglobulins and complement factors in senile plaques. An immunohistochemical study.Acta Neuropath. (Berl)57, 239\u2013242.","journal-title":"Acta Neuropath. (Berl)"},{"key":"BF02815208_CR13","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1073\/pnas.86.19.7606","volume":"86","author":"D. Goldgaber","year":"1989","unstructured":"Goldgaber D., Harris H., Hla T., Maciag T., Donnelly R. J., Jacobsen J. S., Vitek M. P., Guiroy D., and Gajdusek D. C. (1989) Interleukin-1 regulates synthesis of amyloid beta protein precursor mRNA in human endothelial cell.Proc. Natl. Acad. Sci. USA\n86, 7606\u20137610.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02815208_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00005072-199503000-00014","volume":"54","author":"W. S. Griffin","year":"1995","unstructured":"Griffin W. S., Sheng J. G., Roberts G. W., and Mrak R. E. (1995) Interleukin-1 expression in different plaque types in Alzheimer's diseases: significance in plaque evolution.J. Neuropathol. Exp. Neurol.\n54, 276\u2013281.","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BF02815208_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1515\/bchm2.1981.362.1.549","volume":"362","author":"B. Grinde","year":"1981","unstructured":"Grinde B. and Seglen P. O. (1981) Role of microtubuli in lysosomal protein degradation, Hoppe-Seyler's Z.Physiol. Chem.\n362, 549\u2013556.","journal-title":"Physiol. Chem."},{"key":"BF02815208_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/BF00687883","volume":"77","author":"S. Haga","year":"1989","unstructured":"Haga S., Akai K., and Ishii T. (1989) Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain: an immunohistochemical study using a novel monoclonal antibody.Acta Neuropathol.\n77, 569\u2013575.","journal-title":"Acta Neuropathol."},{"key":"BF02815208_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0002-9343(99)80399-4","volume":"98","author":"HERA Study Group","year":"1995","unstructured":"HERA Study Group (1995) A randomized trial of hydroxychloroquine in early rheumatoid arthritis: The HERA Study.Am. J. Med.\n98, 156\u2013168.","journal-title":"Am. J. Med."},{"key":"BF02815208_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0197-4580(94)90141-4","volume":"15","author":"T. R. Hinds","year":"1994","unstructured":"Hinds T. R., Kukull W. A., Van Belle G., Schellenberg G. D., Villacres E. C., and Larson E. B. (1994) Relationship between serum \u03b11-antichymotrypsin and Alzheimer's disease.Neurobiol. Aging\n15, 21\u201327.","journal-title":"Neurobiol. Aging"},{"key":"BF02815208_CR19","first-page":"60","volume":"48","author":"R. Kisilevsky","year":"1983","unstructured":"Kisilevsky R., Boudreau L., and Foster D. (1983) Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy.Lab. Invest.\n48, 60\u201367.","journal-title":"Lab. Invest."},{"key":"BF02815208_CR20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/0006-3223(94)90598-3","volume":"36","author":"U. Lucca","year":"1994","unstructured":"Lucca U., Tettamanti M., Forloni G., and Spagnoli A. (1994) Nonsteroidal anti-inflammatory Drug Use in Alzheimer's Disease.Biol. Psychiatry.\n36, 854\u2013856.","journal-title":"Biol. Psychiatry."},{"key":"BF02815208_CR21","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.410280414","volume":"28","author":"E. Matsubara","year":"1990","unstructured":"Matsubara E., Hirai S., Amari H., Shoji M., Yamaguchi H., Okamoto K., Ishiguro K., Harigaya Y., and Wakabayashi W. (1990) Alpha-1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia.Ann. Neurol.\n28, 561\u2013567.","journal-title":"Ann. Neurol."},{"key":"BF02815208_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0304-3940(87)90696-3","volume":"79","author":"P. L. McGeer","year":"1987","unstructured":"McGeer P. L., Itagaki S., Tago H., and McGeer E. G. (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.Neurosci. Lett.\n79, 195\u2013200.","journal-title":"Neurosci. Lett."},{"key":"BF02815208_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0304-3940(89)90843-4","volume":"107","author":"P. L. McGeer","year":"1989","unstructured":"McGeer P. L., Akiyama H., Itagaki S., and McGeer E. G. (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients.Neurosci. Lett.\n107, 341\u2013346.","journal-title":"Neurosci. Lett."},{"key":"BF02815208_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1212\/WNL.42.2.447","volume":"42","author":"P. L. McGeer","year":"1992","unstructured":"McGeer P. L. and Rogers J. (1992) Medical hypothesis: antiinflammatory agents as a therapeutic approach to Alzheimer's disease.Neurology\n42, 447\u2013449.","journal-title":"Neurology"},{"key":"BF02815208_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/jama.1956.62970090020017k","volume":"161","author":"J. F. Mullins","year":"1956","unstructured":"Mullins J. F., Watts F. L., and Wilson C. J. (1956) Plaquenil in the treatment of lupus erythematosus.J. Amer. Med. Assoc.\n161, 879\u2013888.","journal-title":"J. Amer. Med. Assoc."},{"key":"BF02815208_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/jnr.490400515","volume":"40","author":"L. M. Refolo","year":"1995","unstructured":"Refolo L. M., Sambamurti K., Efthimiopoulos S., Pappolla M. A., and Robakis N. K. (1995) Evidence that secretase cleavage of cell surface Alzheimer amyloid precursor occurs after normal endocytotic internalization.J. Neurosci. Res.\n40, 694\u2013706.","journal-title":"J. Neurosci. Res."},{"key":"BF02815208_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1212\/WNL.45.1.51","volume":"45","author":"J. B. Rich","year":"1995","unstructured":"Rich J. B., Rasmusson D. X., Folstein M. F., Carson K. A., Kawas C., and Brandt J. (1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.Neurology\n45, 51\u201355.","journal-title":"Neurology"},{"key":"BF02815208_CR28","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1212\/WNL.43.8.1609","volume":"43","author":"J. Rogers","year":"1993","unstructured":"Rogers J., Kirby L. C., Hempelman S. R., Berry D. L., McGeer P. L., Kaszniak A. W., Zalinski J., Cofield M., Mansukhani L., Willson P., and Kogan F. (1993) Clinical trial of indomethacin in Alzheimer's disease.Neurology\n43, 1609\u20131611.","journal-title":"Neurology"},{"key":"BF02815208_CR29","first-page":"439","volume":"45","author":"J. Rogers","year":"1995","unstructured":"Rogers J. (1995) Inflammation as a pathogenic mechanism in Alzheimer's disease.Arzneim-Forsch\/Drug Res.\n45, 439\u2013442.","journal-title":"Arzneim-Forsch\/Drug Res."},{"key":"BF02815208_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0304-3940(90)90759-3","volume":"109","author":"J. M. Rozemuller","year":"1990","unstructured":"Rozemuller J. M., Stam F. C., and Eikelenboom P. (1990) Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease.Neurosci. Lett.\n109, 75\u201378.","journal-title":"Neurosci. Lett."},{"issue":"1A","key":"BF02815208_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0002-9343(83)91266-4","volume":"75","author":"G. Salmeron","year":"1983","unstructured":"Salmeron G. and Lipsky P. E. (1983) Immunosuppressive potential of antimalarials.Am. J. Med.\n75(1A), 19\u201324.","journal-title":"Am. J. Med."},{"key":"BF02815208_CR32","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1084\/jem.140.4.1102","volume":"140","author":"T. Shirahama","year":"1974","unstructured":"Shirahama T. and Cohen A. S. (1974) Blockage of amyloid induction by colchicine in an animal model.J. Exp. Med.\n140, 1102\u20131107.","journal-title":"J. Exp. Med."},{"key":"BF02815208_CR33","first-page":"803","volume":"20","author":"K. Sperber","year":"1993","unstructured":"Sperber K., Quraishi H., Kalb T. H., Panja A., Stecher V., and Mayer L. (1993) Selective regulation of cytokine secretion by hydroxychloroquine: Inhibition of interleukin 1 alpha (IL-1-\u03b1) and IL-6 in human monocytes and T cells.J. Rheumatol.\n20, 803\u2013808.","journal-title":"J. Rheumatol."},{"key":"BF02815208_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0167-5699(91)90032-O","volume":"12","author":"P. Vandenabeele","year":"1991","unstructured":"Vandenabeele P. and Fiers W. (1991) Is amyloidogenesis during Alzheimer's disease due to an IL-1\/IL-6-mediated \u2018acute phase response\u2019 in the brain?Immunol. Today\n12, 217\u2013219.","journal-title":"Immunol. Today"},{"key":"BF02815208_CR35","first-page":"99","volume-title":"Frontiers of Alzheimer Research","author":"H. Wisniewski","year":"1991","unstructured":"Wisniewski H., Wegiel J., Strojny P., Wang K.-C., Kim K.-S., and Burrage T. (1991) Ultrastructural morphology and immunocytochemistry of beta amyloid classical, primitive and diffuse plaques, inFrontiers of Alzheimer Research (Ishii T., ed.), pp. 99\u2013108, Elsevier, Amsterdam."},{"key":"BF02815208_CR36","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","volume":"314","author":"D. Zemer","year":"1986","unstructured":"Zemer D., Pras M., Sohar E., Modon M., Cabili S., and Gafni J. (1986) Colchicine in the prevention and treatment of amyloidosis of familial Mediterranean fever.N. Engl. J. Med.\n314, 1001\u20131005.","journal-title":"N. Engl. J. Med."},{"key":"BF02815208_CR37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7326\/0003-4819-116-5-426_1","volume":"116","author":"D. Zemer","year":"1992","unstructured":"Zemer D., Livneh A., and Langevitz P. (1992) Reversal of the nephrotic syndrome by colchicine in amyloidosis of familial Mediterranean fever.Ann. Intern. Med.\n116, 426.","journal-title":"Ann. Intern. Med."}],"container-title":["Molecular and chemical neuropathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02815208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02815208\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02815208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02815208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T01:36:18Z","timestamp":1567474578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02815208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":37,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["BF02815208"],"URL":"https:\/\/doi.org\/10.1007\/bf02815208","relation":{},"ISSN":["1044-7393"],"issn-type":[{"value":"1044-7393","type":"print"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}